LEVETIRACETAM TEVA ® 250 MG

国: イスラエル

言語: 英語

ソース: Ministry of Health

有効成分:

LEVETIRACETAM 250 MG

から入手可能:

TEVA PHARMACEUTICAL INDUST.LTD

ATCコード:

N03AX14

医薬品形態:

TABLETS

投与経路:

PER OS

製:

TEVA PHARMACEUTICAL INDUSTRIES LTD

治療群:

LEVETIRACETAM

適応症:

- Levetiracetam is indicated as adjunctive therapy in the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy. - Levetiracetam is indicated as adjunctive therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy.- Levetiracetam is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in patient from 16 years of age with newly diagnosed epilepsy.- Levetiracetam is indicated in the treatment of primary gneralized tonic-clonic seizures in adults and adolescents from 12 years of age with idiopathic generalised epilepsy.

承認日:

2009-09-01